Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

366 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.
Alton EWFW, Armstrong DK, Ashby D, Bayfield KJ, Bilton D, Bloomfield EV, Boyd AC, Brand J, Buchan R, Calcedo R, Carvelli P, Chan M, Cheng SH, Collie DDS, Cunningham S, Davidson HE, Davies G, Davies JC, Davies LA, Dewar MH, Doherty A, Donovan J, Dwyer NS, Elgmati HI, Featherstone RF, Gavino J, Gea-Sorli S, Geddes DM, Gibson JSR, Gill DR, Greening AP, Griesenbach U, Hansell DM, Harman K, Higgins TE, Hodges SL, Hyde SC, Hyndman L, Innes JA, Jacob J, Jones N, Keogh BF, Limberis MP, Lloyd-Evans P, Maclean AW, Manvell MC, McCormick D, McGovern M, McLachlan G, Meng C, Montero MA, Milligan H, Moyce LJ, Murray GD, Nicholson AG, Osadolor T, Parra-Leiton J, Porteous DJ, Pringle IA, Punch EK, Pytel KM, Quittner AL, Rivellini G, Saunders CJ, Scheule RK, Sheard S, Simmonds NJ, Smith K, Smith SN, Soussi N, Soussi S, Spearing EJ, Stevenson BJ, Sumner-Jones SG, Turkkila M, Ureta RP, Waller MD, Wasowicz MY, Wilson JM, Wolstenholme-Hogg P; UK Cystic Fibrosis Gene Therapy Consortium. Alton EWFW, et al. Among authors: ashby d. Lancet Respir Med. 2015 Sep;3(9):684-691. doi: 10.1016/S2213-2600(15)00245-3. Epub 2015 Jul 3. Lancet Respir Med. 2015. PMID: 26149841 Free PMC article. Clinical Trial.
Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation.
Horsley AR, Davies JC, Gray RD, Macleod KA, Donovan J, Aziz ZA, Bell NJ, Rainer M, Mt-Isa S, Voase N, Dewar MH, Saunders C, Gibson JS, Parra-Leiton J, Larsen MD, Jeswiet S, Soussi S, Bakar Y, Meister MG, Tyler P, Doherty A, Hansell DM, Ashby D, Hyde SC, Gill DR, Greening AP, Porteous DJ, Innes JA, Boyd AC, Griesenbach U, Cunningham S, Alton EW. Horsley AR, et al. Among authors: ashby d. Thorax. 2013 Jun;68(6):532-9. doi: 10.1136/thoraxjnl-2012-202538. Epub 2013 Feb 9. Thorax. 2013. PMID: 23396354 Clinical Trial.
Oral steroids for long-term use in cystic fibrosis.
Cheng K, Ashby D, Smyth RL. Cheng K, et al. Among authors: ashby d. Cochrane Database Syst Rev. 2013 Jun 24;(6):CD000407. doi: 10.1002/14651858.CD000407.pub3. Cochrane Database Syst Rev. 2013. PMID: 23794322 Updated. Review.
Ursodeoxycholic acid for cystic fibrosis-related liver disease.
Cheng K, Ashby D, Smyth RL. Cheng K, et al. Among authors: ashby d. Cochrane Database Syst Rev. 2017 Sep 11;9(9):CD000222. doi: 10.1002/14651858.CD000222.pub4. Cochrane Database Syst Rev. 2017. PMID: 28891588 Free PMC article. Review.
Oral steroids for long-term use in cystic fibrosis.
Cheng K, Ashby D, Smyth RL. Cheng K, et al. Among authors: ashby d. Cochrane Database Syst Rev. 2015 Dec 9;2015(12):CD000407. doi: 10.1002/14651858.CD000407.pub4. Cochrane Database Syst Rev. 2015. PMID: 26649765 Free PMC article. Review.
Ursodeoxycholic acid for cystic fibrosis-related liver disease.
Cheng K, Ashby D, Smyth RL. Cheng K, et al. Among authors: ashby d. Cochrane Database Syst Rev. 2014 Dec 15;(12):CD000222. doi: 10.1002/14651858.CD000222.pub3. Cochrane Database Syst Rev. 2014. PMID: 25501301 Updated. Review.
Ursodeoxycholic acid for cystic fibrosis-related liver disease.
Cheng K, Ashby D, Smyth RL. Cheng K, et al. Among authors: ashby d. Cochrane Database Syst Rev. 2012 Oct 17;10:CD000222. doi: 10.1002/14651858.CD000222.pub2. Cochrane Database Syst Rev. 2012. PMID: 23076885 Updated. Review.
Oral steroids for long-term use in cystic fibrosis.
Cheng K, Ashby D, Smyth RL. Cheng K, et al. Among authors: ashby d. Cochrane Database Syst Rev. 2011 Oct 5;(10):CD000407. doi: 10.1002/14651858.CD000407.pub2. Cochrane Database Syst Rev. 2011. PMID: 21975730 Updated. Review.
366 results